Select Committee on Innovation, Universities and Skills Minutes of Evidence


Examination of Witnesses (Questions 60-79)

SIR LESZEK BORYSIEWICZ, DR MARK WALPORT, PROFESSOR MALCOLM GRANT, AND MRS LYNN ROBB

17 DECEMBER 2007

  Q60  Dr Iddon: How many are at the Mill Hill site, Sir Leszek?

  Sir Leszek Borysiewicz: About 700.

  Q61  Dr Iddon: So there will be an expansion if you say the British Library site can house 1500.

  Sir Leszek Borysiewicz: It is very dependent on how the proposed building is configured, which is in turn dependent on the nature of the science that we undertake. For example, the size of animal facilities, the opportunity for UCL staff who would also be coming into this area would need to be very carefully considered, so just taking the simple numbers against gross areas is the appropriate measure that we should be using at this point. We have to take a step back and think precisely what the science is that we want to do, what are the right circumstances to provide the physical infrastructure and then ensuring that we get the best value for money in terms of the site.

  Q62  Dr Iddon: Is it your intention to vacate the Mill Hill site completely, including the animal laboratories that are there too at the moment?

  Sir Leszek Borysiewicz: The decision that Council has taken remains at the present time the decision that has been ratified again by Council, that we do not intend to remain on the Mill Hill site beyond the development of this new site.

  Q63  Dr Iddon: So the preference is to move the animal laboratories into central London.

  Sir Leszek Borysiewicz: That will certainly be being considered, I am sure, by Sir Paul Nurse in relationship to this area. Will animal facilities be required on a site of this sort? Any site that is actually undertaking biomedical research is going to require animal facilities on such a site and there are other sites in central London which already have animal facilities to enable the science to go forward. The scale and size of that particular development is something that Sir Paul Nurse's committee will have to consider.

  Q64  Dr Iddon: Have you considered the intimidation that the staff who are building the institute and occupying the institute eventually will get from the animal rights activists, who have not gone away?

  Dr Walport: May I just comment on that because actually the Government has taken an extremely strong view on animal rights activists. They are operating outside the law and this is a form of terrorism, and it is good news that the Government and Parliament in general have taken such a strong stance on this, which I hope this Committee supports.

  Q65  Dr Iddon: We have had an almost weekly demonstration, very weak at the moment, up at Mill Hill, I gather, but in the past we have had quite strong demonstrations outside the Mill Hill facilities. I agree with what Mark has said, but nevertheless these are pretty ruthless people and moving into central London just, in my book, makes it easier for them to demonstrate.

  Sir Leszek Borysiewicz: I would reiterate that to my knowledge there are many sites in central London where they could demonstrate in the same way. Clearly, we would take guidance from the security and other services in relationship to this, and this will be part of the consideration we will have to take, but the primary consideration at this point for me is really what is going to be required to deliver the very best science that we envisage.

  Q66  Dr Iddon: On this footprint, Sir Leszek, do you think you will have room for future expansion as new ideas are evolved?

  Sir Leszek Borysiewicz: I believe we will, but we will have to watch this very carefully because, again, the scope and scale of that expansion as to filling the site as of day one is something that has to be very carefully considered. My own view again is that we are dealing with a timeframe that we have to make allowance for in terms of the changing nature of the science. Secondly, we have to ensure that whatever facility is actually constructed is a very flexible facility to be able to accommodate changes in science and, thirdly, we have to consider very carefully what we already have that is of world class quality that Sir Paul Nurse's committee may want to move to that site. It is a balance between those three that I do not think I can strike that balance here and now, it is something that I can only strike with the advice that that committee is going to be able to give me.

  Dr Walport: Science is something that evolves, so it is not a question of continuous expansion in a sense. If you look at the Sanger Institute, which is the institute that the Wellcome Trust largely funds, that started as an institute that was there to sequence the human genome and then subsequently other genomes. If you go there now, which you are very welcome to do, you would find that what that institute is now doing is working to exploit that genome sequence by looking at genetic variation, bringing it to patient populations, and every scientific institution if it is being kept on its toes—which it should be—is actually going to do different science at different periods.

  Q67  Dr Gibson: But that is on a greenfield site, is it not? The Sanger Institute is on a greenfield site, it is well outside Cambridge.

  Dr Walport: Yes, it is, and you can argue that that is a limitation because it does not have the same ready communications that this site would have.

  Q68  Dr Gibson: Would you move that into Cambridge, next door to Addenbrooke's?

  Dr Walport: The Sanger Institute is doing very well at the moment.

  Q69  Dr Iddon: Could I look at the other more important bio-security issue and that is category 3 or category 4 containment. My understanding is that the original plans for the Temperance site put in place a category 3 facility which was capable, I think, of handling avian flu, but in terms of this being one of the leading medical research centres in the world, would it not be better to gear yourselves up for the worst eventuality of handling category 4?

  Sir Leszek Borysiewicz: I am sorry, but I would defer that very much to Sir Paul Nurse's committee because that is precisely the kind of question that he is going to have to address in the context of what is going to be undertaken on this site, so it would be wrong for me to actually prejudice the judgment that his group are likely to make in this regard. They will be proffering us advice on that area and we will be considering that advice very carefully.

  Q70  Dr Iddon: There is still room to put a category 4 facility in there.

  Sir Leszek Borysiewicz: It would have to be one of the considerations; I do not want to lock off that as a possibility from the advice that they may actually be able to give us, but having received that advice, as I have said before, we would certainly need to look at the security issues and the necessity for the build that would actually be required to deliver that safely and effectively at this location.

  Q71  Dr Iddon: Can we control extremely dangerous pathogens in a major city?

  Sir Leszek Borysiewicz: Yes, I believe we can. There are other locations, both within London and other major cities, that house major pathogens that are being very effectively monitored and controlled in this regard.

  Q72  Dr Iddon: I am glad you said that because obviously that is a very important consideration. Turning now to your relationships currently with Camden Council, this site, the British Library site, was originally to be a mixed development of housing and community facilities. Those facilities are desperately needed in the Camden area; indeed, the whole of that area is undergoing regeneration at the moment, and in order to regenerate you need people living in the regenerated areas. Have you been in consultation with Camden Council to see whether they are going to press that mixed development or whether they are going to be prepared to relinquish the site for what Des has called the St Pancras Institute?

  Sir Leszek Borysiewicz: First and foremost let me just say that we have not been in direct contact with Camden Council, it would have been wrong for us to be so while we were actually bidding for this particular site. What we will be looking at is that this site is going to be very full if we are to achieve the sorts of levels of occupancy that I have actually dealt with, so I do not believe that we are going to have much opportunity to provide additional housing on this particular site. Maybe what I would like to do is pass this over also to Professor Grant who has been in contact with Camden during these times.

  Professor Grant: We operate, obviously, within Camden. We are the largest employer within Camden and we have a very good operating relationship with the council. The site was the subject of a planning brief published in 2003 which did indeed indicate a desire on the part of Camden to have housing on the site as part of a mixed use development and 50 per cent of that is affordable housing. The planning brief was then accompanied by the adoption in 2006 of the unitary development plan for Camden and in that plan there is reference to facilities being provided by the public sector and paid for by public money and involving universities, in which it is indicated that the affordable housing requirements would be looked at perhaps in a different way with greater flexibility. We understand from our initial relationships with Camden that they will wish, of course, to try to secure housing and affordable housing in the borough; that is a primary ambition for any inner London council, but that at the same time they recognise the sheer importance of being able to encourage within their area a world-class biomedical research operation, so we will, I think, wish to have discussions with them to try to see how best we can achieve both of those aims, but I have to say, for all the reasons that Leszek has just indicated, this is very early times. We did not want to broach these discussions with them when we were in the process of buying the land because that would have been thought to be unfair to other potential bidders for the land. We would have been seen to be canvassing which we did not want to do.

  Q73  Dr Turner: Have you offered them the NTH site for housing?

  Sir Leszek Borysiewicz: No, we have not offered it because we have not been in contact with Camden to have those levels of discussion so we could not conceivably have offered them any alternative site.

  Q74  Dr Gibson: How much would it cost to buy that land, is your estimate?

  Sir Leszek Borysiewicz: Which land?

  Q75  Dr Gibson: The British Library site.

  Sir Leszek Borysiewicz: It was £85 million.

  Q76  Dr Gibson: Did you beat them down from £100 million?

  Dr Walport: No. We made them an offer which they accepted.

  Q77  Chairman: In terms of the Temperance Hospital site, does that become part of the overall bargaining with Camden? That is the question we would like to put.

  Sir Leszek Borysiewicz: At the present time what can I say in terms of the MRC? If we were to go ahead with this particular development then clearly the Temperance Hospital site is above the requirements of the MRC and we would be looking to dispose of that site in due course, but that is as far as I can take it at this point.

  Q78  Graham Stringer: I understand the current estimate of the total cost of this project is £500 million. What is the breakdown between the partners of that figure? First of all, is that figure accurate?

  Sir Leszek Borysiewicz: It is a broad figure at the present time that is being used by many in terms of the area and it is a reasonably accurate figure overall but it does have some caveats. It does not have, for example, the land costs built into those sorts of numbers. The current breakdown, I think, is that the MRC are looking at round about £260 million overall for that budget, and I think it is £150 million for Cancer Research UK and £100 million for the Wellcome Trust.

  Professor Grant: And £46 million for UCL.

  Q79  Graham Stringer: Of the MRC contribution how much is to be met by a grant from the Large Facilities Capital Fund?

  Sir Leszek Borysiewicz: At the present time we are in discussion with DIUS as to what would be the appropriate sum that we would come forward for from the Large Facilities Capital Fund. We certainly expect that to be quite a large bid at this stage, certainly in the order of £180 million to £200 million, but it would be for a bid that would be for expenditure outside the current CSR because of some of the other calls that are there.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2008
Prepared 23 January 2008